A Case Series Examining PTSD and Depression Symptom Reductions Over the Course of a 2-Week Virtual Intensive PTSD Treatment Program for Veterans

被引:10
|
作者
Held, Philip [1 ]
Coleman, Jennifer A. [1 ]
Petrey, Kelsey [1 ]
Klassen, Brian J. [1 ]
Pridgen, Sarah [1 ]
Bravo, Karyna [1 ]
Smith, Dale L. [2 ]
Van Horn, Rebecca [1 ]
机构
[1] Rush Univ, Dept Psychiat & Behav Sci, Med Ctr, 325 South,Paulina St,2nd Floor, Chicago, IL 60612 USA
[2] Olivet Nazarene Univ, Dept Behav Sci, Bourbonnais, IL USA
关键词
PTSD; telehealth; veterans; intensive treatment; cognitive processing therapy; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PROCESSING THERAPY; HEALTH; PSYCHOTHERAPY; VALIDATION; DELIVERY; AUDIT; PCL-5;
D O I
10.1037/tra0001106
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Clinical Impact Statement The present case series suggests that delivering posttraumatic stress disorder (PTSD) treatments via telehealth twice per day for 2 consecutive weeks can reduce PTSD and depression symptom severity. Telehealth can greatly expand the reach of these intensive PTSD treatment programs, which may be particularly relevant for individuals who would be unable to travel to treatment sites. When offering intensive PTSD treatment virtually, clinicians are strongly encouraged to follow the American Psychological Association's telehealth best practice guidelines for establishing safety and determining the patients' homes provide a safe and feasible environment for participating in treatment. Objective: Evidence-based treatments for posttraumatic stress disorder (PTSD) can be effectively delivered over telehealth. There are, however, no studies that examine the effectiveness of delivering evidence-based treatments for PTSD in an intensive format via telehealth. Telehealth may be well-suited as a delivery modality because it may address barriers specific to intensive treatments. Method: To address this gap, we report on a case series of ten consecutively enrolled veterans (60% male; mean age 42.3, SD = 6.3) who participated in a virtual 2-week, cognitive processing therapy (CPT)-based intensive program. Results: All (100%) participants completed treatment and reported large reductions in PTSD and depression symptoms pre- to posttreatment (Hedge's g(ws) = 2.83 and g(ws) = 1.97, respectively), pre- to 3-month follow-up (Hedge's g(ws) = .99 and g(ws) = 1.24, respectively), as well as very high satisfaction. Conclusions: Results of this case series suggest that evidence-based treatments for PTSD can be effectively delivered in intensive formats over telehealth and lay the foundation for more rigorously designed and larger scale research comparing virtual to in-person delivered intensive PTSD treatments.
引用
收藏
页码:615 / 623
页数:9
相关论文
共 10 条
  • [1] Examining the effectiveness of an intensive, 2-week treatment program for military personnel and veterans with PTSD: Results of a pilot, open-label, prospective cohort trial
    Bryan, Craig J.
    Leifker, Feea R.
    Rozek, David C.
    Bryan, AnnaBelle O.
    Reynolds, Mira L.
    Oakey, D. Nicolas
    Roberge, Erika
    JOURNAL OF CLINICAL PSYCHOLOGY, 2018, 74 (12) : 2070 - 2081
  • [2] Feasibility of a 3-Week Intensive Treatment Program for Service Members and Veterans With PTSD
    Held, Philip
    Klassen, Brian J.
    Boley, Randy A.
    Stirman, Shannon Wiltsey
    Smith, Dale L.
    Brennan, Michael B.
    Van Horn, Rebecca
    Pollack, Mark H.
    Karnik, Niranjan S.
    Zalta, Alyson K.
    PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY, 2020, 12 (04) : 422 - 430
  • [3] Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD
    Alyson K. Zalta
    Philip Held
    Dale L. Smith
    Brian J. Klassen
    Ashton M. Lofgreen
    Patricia S. Normand
    Michael B. Brennan
    Thad S. Rydberg
    Randy A. Boley
    Mark H. Pollack
    Niranjan S. Karnik
    BMC Psychiatry, 18
  • [4] Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD
    Zalta, Alyson K.
    Held, Philip
    Smith, Dale L.
    Klassen, Brian J.
    Lofgreen, Ashton M.
    Normand, Patricia S.
    Brennan, Michael B.
    Rydberg, Thad S.
    Boley, Randy A.
    Pollack, Mark H.
    Karnik, Niranjan S.
    BMC PSYCHIATRY, 2018, 18
  • [5] Delivering Intensive PTSD Treatment Virtually: The Development of a 2-Week Intensive Cognitive Processing Therapy-Based Program in Response to COVID-19
    Held, Philip
    Klassen, Brian J.
    Coleman, Jennifer A.
    Thompson, Kaitlin
    Rydberg, Thad S.
    Van Horn, Rebecca
    COGNITIVE AND BEHAVIORAL PRACTICE, 2021, 28 (04) : 543 - 554
  • [6] Veterans' 12-month PTSD and depression outcomes following 2-and 3-week intensive cognitive processing therapy-based treatment
    Held, Philip
    Smith, Lia J.
    Parmar, Angelee M.
    Pridgen, Sarah A.
    Smith, Dale L.
    Klassen, Brian
    EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY, 2024, 15 (01)
  • [7] Effects of Intranasal (S)-Ketamine on Veterans With Co-Morbid Treatment-Resistant Depression and PTSD: A Retrospective Case Series
    Artin, Hewa
    Bentley, Sean
    Mehaffey, Eamonn
    Liu, Fred
    Sojourner, Kevin
    Bismark, Andrew
    Printz, David
    Lee, Ellen
    Martis, Brian
    De Peralta, Sharon
    Baker, Dewleen
    Mishra, Jyoti
    Ramanathan, Dhakshin
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 113 - 114
  • [8] Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series
    Artin, Hewa
    Bentley, Sean
    Mehaffey, Eamonn
    Liu, Fred X.
    Sojourner, Kevin
    Bismark, Andrew W.
    Printz, David
    Lee, Ellen E.
    Martis, Brian
    De Peralta, Sharon
    Baker, Dewleen G.
    Mishra, Jyoti
    Ramanathan, Dhakshin
    ECLINICALMEDICINE, 2022, 48
  • [9] Substance Use after Completion of an Intensive Treatment Program with Concurrent Treatment for Posttraumatic Stress Disorder and Substance Use among Veterans: Examining the Role of PTSD Symptoms
    Watkins, Laura E.
    Patton, Samantha C.
    Wilcox, Tiffany
    Drexler, Karen
    Rauch, Sheila A. M.
    Rothbaum, Barbara O.
    JOURNAL OF DUAL DIAGNOSIS, 2024, 20 (01) : 16 - 28
  • [10] Clinical Efficacy of a 2-Week Treatment Course of Zuranolone for the Treatment of Major Depressive Disorder and Postpartum Depression: Outcomes From the Clinical Development Program
    Clayton, A.
    Cutler, A. J.
    Deligiannidis, K. M.
    Lasser, R.
    Sankoh, J.
    Doherty, J.
    Kotecha, M.
    EUROPEAN PSYCHIATRY, 2022, 65 : S97 - S98